SRRK

Scholar Rock Holding Corporation

15.88 USD
+0.28 (+1.79%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Scholar Rock Holding Corporation stock is up 8.69% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 February’s closed higher than January. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Dec 17:38 19 Jan, 2024 12.50 CALL 50 319
27 Dec 17:53 19 Jan, 2024 12.50 CALL 50 319
28 Dec 18:51 19 Jan, 2024 12.50 CALL 50 273
02 Jan 15:25 19 Jan, 2024 12.50 CALL 55 273

About Scholar Rock Holding Corporation

Scholar Rock Holding Corporation focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin, and SRK-181, which is in Phase 1 clinical trials. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients.